146 related articles for article (PubMed ID: 38786003)
1. PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis.
Zhang S; Wang Y; Gu J; Yang Y; Liang J; Wang Y; Ji N; Liu M; Zhang Y; Sun S; Chen Q; Li J
Biomolecules; 2024 May; 14(5):. PubMed ID: 38786003
[TBL] [Abstract][Full Text] [Related]
2. Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11.
Liang B; Wu Y
Arch Oral Biol; 2023 Dec; 156():105807. PubMed ID: 37776596
[TBL] [Abstract][Full Text] [Related]
3. Astaxanthin Synergizes with Ionizing Radiation (IR) in Oral Squamous Cell Carcinoma (OSCC).
Du Y; Shuai Y; Liu Z; Li H; Yin Y
Mol Biotechnol; 2024 May; 66(5):1220-1228. PubMed ID: 38103098
[TBL] [Abstract][Full Text] [Related]
4. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway.
Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H
Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316
[TBL] [Abstract][Full Text] [Related]
5. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
6. MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11.
Sun K; Ren W; Li S; Zheng J; Huang Y; Zhi K; Gao L
Pathol Res Pract; 2022 Mar; 231():153778. PubMed ID: 35093695
[TBL] [Abstract][Full Text] [Related]
7. NFE2L1 restrains ferroptosis by transcriptionally regulating HJURP and participates in the progress of oral squamous cell carcinoma.
Zhang M; Wang Z; Yang G; Han L; Wang X
J Bioenerg Biomembr; 2023 Dec; 55(6):467-478. PubMed ID: 37848756
[TBL] [Abstract][Full Text] [Related]
8. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.
Wang Z; Tang S; Cai L; Wang Q; Pan D; Dong Y; Zhou H; Li J; Ji N; Zeng X; Zhou Y; Shen YQ; Chen Q
Br J Cancer; 2024 May; 130(11):1744-1757. PubMed ID: 38582810
[TBL] [Abstract][Full Text] [Related]
9. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
[TBL] [Abstract][Full Text] [Related]
10. CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells.
Xie J; Lan T; Zheng DL; Ding LC; Lu YG
BMC Oral Health; 2023 May; 23(1):329. PubMed ID: 37237299
[TBL] [Abstract][Full Text] [Related]
11. Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1.
Wen Z; Zhang Y; Gao B; Chen X
J Gene Med; 2024 Feb; 26(2):e3669. PubMed ID: 38380717
[TBL] [Abstract][Full Text] [Related]
12. An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment.
Zhao X; Leng D; Wang H; Jin H; Wu Y; Qin Z; Wu D; Wei X
J Dent Res; 2024 Jun; 103(6):612-621. PubMed ID: 38684484
[TBL] [Abstract][Full Text] [Related]
13. Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
Hamilton KL; Sheehan SA; Retzbach EP; Timmerman CA; Gianneschi GB; Tempera PJ; Balachandran P; Goldberg GS
J Cancer Res Clin Oncol; 2021 Feb; 147(2):445-457. PubMed ID: 33205348
[TBL] [Abstract][Full Text] [Related]
14. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis.
Chang LC; Chiang SK; Chen SE; Yu YL; Chou RH; Chang WC
Cancer Lett; 2018 Mar; 416():124-137. PubMed ID: 29274359
[TBL] [Abstract][Full Text] [Related]
16. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
18. Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637.
Zheng X; Du F; Gong X; Xu P
Bioengineered; 2022 Jan; 13(1):440-454. PubMed ID: 34967281
[TBL] [Abstract][Full Text] [Related]
19. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
Yang J; Zhou Y; Xie S; Wang J; Li Z; Chen L; Mao M; Chen C; Huang A; Chen Y; Zhang X; Khan NUH; Wang L; Zhou J
J Exp Clin Cancer Res; 2021 Jun; 40(1):206. PubMed ID: 34162423
[TBL] [Abstract][Full Text] [Related]
20. Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells.
Han L; Li L; Wu G
Mol Cell Probes; 2022 Aug; 64():101821. PubMed ID: 35490795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
